PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc., (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the fourth quarter and full year ended December 31, 2008, on Wednesday, March 25, 2009, after the close of the financial markets. Management will conduct a conference call on Thursday, March 26, 2009 at 10:00 a.m. Eastern Time to review the results for the quarter and the year. Ralph Makar, President and CEO, Dr. Richard Stout, Executive Vice President and Chief Medical Officer and Chris Farrell, Vice President of Finance, will be hosting the call.
